Ishwaria Subbiah on Elderly Patients Enrolling in Clinical Trials
Ishwaria Mohan Subbiah, MD, of MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials. Ishwaria Mohan Subbiah, MD, MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials.
Ishwaria Mohan Subbiah, MD, of MD Anderson Cancer Center, discusses the importance of elderly patients enrolling in clinical trials.
It is important to empower patients over the age of 65 to learn about, consider, and discuss with their healthcare team the possibility of going on a clinical trial. Patients should be as educated as possible, and thanks to resources like clinicaltrials.gov, that knowledge is more accessible than ever. However, many patients are still apprehensive about enrolling, so it is crucial for the healthcare team to work to address these fears.
Subbiah conducted a study that found although elderly patients make up more than 50% of the new cancer diagnoses in the United States each year, they are a much smaller proportion of patients enrolled in clinical trials. To ensure that trials accurately represent the people who are getting cancer, more people over the age of 65 should enroll.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
